Restoration of mitochondria function as a target for cancer therapy

Drug Discovery Today
Tariq A BhatDhyan Chandra

Abstract

Defective oxidative phosphorylation has a crucial role in the attenuation of mitochondrial function, which confers therapy resistance in cancer. Various factors, including endogenous heat shock proteins (HSPs) and exogenous agents such as dichloroacetate, restore respiratory and other physiological functions of mitochondria in cancer cells. Functional mitochondria might ultimately lead to the restoration of apoptosis in cancer cells that are refractory to current anticancer agents. Here, we summarize the key reasons contributing to mitochondria dysfunction in cancer cells and how restoration of mitochondrial function could be exploited for cancer therapeutics.

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 21, 2002·Trends in Endocrinology and Metabolism : TEM·David R Plas, Craig B Thompson
Mar 26, 2003·Seminars in Cancer Biology·Boris Zhivotovsky, Sten Orrenius
Feb 24, 1956·Science·O WARBURG
Dec 13, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Tetsuo Mashima, Takashi Tsuruo
Mar 18, 2006·Cell Death and Differentiation·J E Chipuk, D R Green
Jun 10, 2006·Cell Death and Differentiation·K B SpurgersT J McDonnell
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zejia YangKevin J Cullen
Oct 19, 2006·Journal of the National Cancer Institute·Arata TomiyamaChifumi Kitanaka
Oct 9, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Tariq A Bhat, Rana P Singh
Jun 10, 2008·Cancer Cell·Guido Kroemer, Jacques Pouyssegur
Jun 11, 2008·The Journal of Biological Chemistry·Thomas McFateAjay Verma
Nov 26, 2008·Nature Cell Biology·Allyson E Vaughn, Mohanish Deshmukh
Mar 10, 2009·Genes & Development·Russell G Jones, Craig B Thompson
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
Aug 26, 2009·Cell·Agnieszka ChacinskaNikolaus Pfanner
Dec 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Shanta Dhar, Stephen J Lippard
Mar 10, 2010·Environmental and Molecular Mutagenesis·David M Hockenbery
May 14, 2010·Science Translational Medicine·E D MichelakisK C Petruk
Jun 24, 2010·Trends in Biochemical Sciences·David R Wise, Craig B Thompson
Aug 5, 2010·Nature Reviews. Molecular Cell Biology·Stephen W G Tait, Douglas R Green
Sep 17, 2010·Journal of Cell Science·Shawn B Bratton, Guy S Salvesen
Nov 5, 2010·Journal of Cell Science·Cole M Haynes, David Ron
Nov 16, 2010·Biochimica Et Biophysica Acta·Dhyan Chandra, Keshav K Singh
Feb 18, 2011·Biotechnology and Bioengineering·Ning Zhang, Andre F Palmer
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 16, 2011·Journal of Biomedicine & Biotechnology·Jingtao TongHoujie Liang
Apr 22, 2011·Nature Reviews. Cancer·Willem H KoppenolChi V Dang
May 11, 2011·International Journal of Cancer. Journal International Du Cancer·Serena VellaAldo Pagano
Dec 23, 2011·Current Pharmaceutical Design·Vladimir Gogvadze

❮ Previous
Next ❯

Citations

Dec 1, 2015·Journal of Biochemical and Molecular Toxicology·Ling LiuShuying Wang
Nov 3, 2016·Journal of the American Society of Nephrology : JASN·Ramindhu GalgamuwaAngelo Theodoratos
Mar 17, 2016·Journal of Experimental & Clinical Cancer Research : CR·Koichi FujisawaIsao Sakaida
May 12, 2016·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Eugenia Tsybul'koElena Pasyukova
Mar 1, 2017·Journal of Cellular and Molecular Medicine·Jarmila NavrátilováPetr Beneš
Feb 9, 2017·Frontiers in Oncology·Eduardo N Maldonado
Oct 4, 2019·Antioxidants & Redox Signaling·Hsin Yao ChiuReshma Taneja
Sep 19, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yuan WangDario C Altieri
Aug 28, 2019·Oncology Letters·Guochao YangHongtao Cheng
May 29, 2016·The Biochemical Journal·Yangzom D BhutiaVadivel Ganapathy
Sep 27, 2020·International Journal of Molecular Sciences·Shalini ManiKeshav K Singh
Jan 24, 2020·Cellular and Molecular Life Sciences : CMLS·Russel J ReiterLuiz G de Almeida Chuffa
Jul 8, 2016·World Journal of Surgery·Yi-Chiung HsuShih-Ping Cheng
Sep 15, 2018·Cancer Control : Journal of the Moffitt Cancer Center·Anna M Bielecka-WajdmanEwa Obuchowicz
Jan 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yue YangNing Li
Feb 14, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Tamara ZwainKamalinder K Singh
Aug 10, 2021·World Journal of Stem Cells·Li-Fang GuYan-Zhou Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.